DRD2 and autoimmune pancreatitis: Studies that focus specifically on pharmacogenetics of antipsychotic-induced parkinsonism (AIP) are few, and have mostly concentrated on functional variants within selected candidate genes such as the dopamine receptors DRD2 and DRD3 and serotonin receptors HTR2A and HTR2C (16, 17).